A randomized, double-blind, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for Metastatic Triple-Negative Breast Cancer (FRIDA)

Type of Cancer
Breast Oncology

Site
Sparta

Sponsor
Dompe

Protocol Number
REP-0114

To Learn More Call
201-510-0910